These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6120256)

  • 61. [Clinical pharmacology of beta adrenergic blocking agents].
    Toyama S; Suzuki K
    Nihon Rinsho; 1973 Sep; 31(9):2687-95. PubMed ID: 4148964
    [No Abstract]   [Full Text] [Related]  

  • 62. Beta-adrenoceptor blocking drugs.
    Prichard BN
    Practitioner; 1977 Oct; 219(1312):501-8. PubMed ID: 22852
    [No Abstract]   [Full Text] [Related]  

  • 63. Letter: Beta-blocking drugs.
    Wall B
    Med J Aust; 1973 Sep; 2(12):617-8. PubMed ID: 4149943
    [No Abstract]   [Full Text] [Related]  

  • 64. [Cardiovascular effects of hydroxytyramine (dopamine) and its importance for the therapy of cardiogenic shock in heart infarct. 2. Experimental studies on hypodynamic hearts of dogs].
    Urbaszek W; Günther K; Trenckmann H; Döring D
    Z Gesamte Inn Med; 1970 Apr; 25(7):290-3. PubMed ID: 4398843
    [No Abstract]   [Full Text] [Related]  

  • 65. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
    Hansen O; Johansson BW
    J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The use of beta adrenergic blocking drugs in cardiovascular disease.
    Prichard BN
    Scott Med J; 1976 Oct; 21(4):182-7. PubMed ID: 11558
    [No Abstract]   [Full Text] [Related]  

  • 67. [Beta-adrenergic blockaders in cardiology].
    Muniz M
    Arq Bras Cardiol; 1979 Oct; 33(4):283-92. PubMed ID: 44836
    [No Abstract]   [Full Text] [Related]  

  • 68. [Up-dating the treatment with beta-blockaders in cardiology].
    Rubio Sanz R; Asin Cardiel E; Rubio Sanz J
    Rev Clin Esp; 1977 Oct; 147(1):103-12. PubMed ID: 22106
    [No Abstract]   [Full Text] [Related]  

  • 69. Anti-arrhythmic effect of DL-propranolol, D-propranolol and I. C. I. 50 172 in experimental myocardial infarction in the dog.
    Staszewska-Barczak J
    Acta Physiol Pol; 1970; 21(3):260-70. PubMed ID: 4396953
    [No Abstract]   [Full Text] [Related]  

  • 70. [Effect of the combined use of nitrates and beta-adrenergic blockaders on hemodynamics in patients with acute myocardial infarction].
    Gvatua NA; Kravtsov VL; Shumakov VA; Beziuk NN; Galitskaia AK
    Kardiologiia; 1983 Sep; 23(9):29-32. PubMed ID: 6417391
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Use of alpha-adrenoblockaders in cardiology].
    Dormidontov EN; Khrustalev OA; Aminov VN
    Kardiologiia; 1980 Nov; 20(11):103-7. PubMed ID: 6108379
    [No Abstract]   [Full Text] [Related]  

  • 72. The cardiovascular actions of the beta-adrenoceptor antagonists.
    Ungar A
    Eur J Clin Invest; 1979 Jun; 9(3):175-7. PubMed ID: 38967
    [No Abstract]   [Full Text] [Related]  

  • 73. [Treatment of patients with myocardial infarct and hyperdynamic syndrome with propranolol].
    Golikov AP; Riabinin VA; Polumiskov VIu; Berestov AA
    Kardiologiia; 1983 Sep; 23(9):24-9. PubMed ID: 6645186
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Can beta blockers limit myocardial infarct size?
    Hearse DJ; Yellon DM; Downey JM
    Eur Heart J; 1986 Nov; 7(11):925-30. PubMed ID: 2878807
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Professor Peter Sleight's reflections on the use of beta-blocking agents after myocardial infarction.
    Sleight P
    Am Heart J; 1997 Aug; 134(2 Pt 2):S15-20. PubMed ID: 9313619
    [No Abstract]   [Full Text] [Related]  

  • 76. Effects of pindolol therapy on the size of experimentally induced myocardial infarction in the pig.
    Friedli HP; Althaus U; Magnenat L; Gurtner HP
    Clin Cardiol; 1986 Apr; 9(4):157-60. PubMed ID: 3720043
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of beta-blockers on arrhythmias.
    Husaini M
    Br Med J; 1979 Sep; 2(6193):794. PubMed ID: 42467
    [No Abstract]   [Full Text] [Related]  

  • 78. [Use of peripheral vasodilators and beta-adrenergic blockaders in the acute period of myocardial infarction (hemodynamic and metabolic aspects)].
    Vakhliaev VD; Pomerantsev EV; Alliluev IG; Zaĭtseva NS; Nesterova LA
    Kardiologiia; 1983 Sep; 23(9):32-7. PubMed ID: 6645187
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Critical appraisal of secondary prevention after myocardial infarction. What have beta-blockers to offer in the experimental situation?
    Parratt JR
    Eur Heart J; 1986 Jul; 7 Suppl B():19-25. PubMed ID: 2875873
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Why do beta-receptor blockers decrease mortality after myocardial infarction?
    Lichstein E
    J Am Coll Cardiol; 1985 Nov; 6(5):973-5. PubMed ID: 2864366
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.